Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 45OTHER 36OTHER_GOV 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 11Thoracic 5Gynecologic 3Dermatologic 3CNS 3Breast 3Tumor-Agnostic 2Endocrine 2Other solid neoplasm 1NET 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 208Carcinoma, Ovarian Epithelial 133Fallopian Tube Neoplasms 117Uterine Cervical Neoplasms 103Breast Neoplasms 76Endometrial Neoplasms 73Pancreatic Neoplasms 33Neoplasms 31Colonic Neoplasms 28Stomach Neoplasms 27Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Testicular Neoplasms 24Sarcoma 23Lung Neoplasms 23Melanoma 22Carcinoma, Renal Cell 22Rectal Neoplasms 21Colorectal Neoplasms 20Vaginal Neoplasms 18Uterine Cervical Dysplasia 18Carcinoma, Hepatocellular 18Neoplasm Metastasis 17Anus Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Esophageal Neoplasms 16Brenner Tumor 16Urinary Bladder Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Vulvar Neoplasms 14

Interventions

Paclitaxel 2peginterferon alfa-2b 1interferon gamma-1b 1Taxes 1Immunoglobulin G 1Gemcitabine 1Fluorouracil 1Docetaxel 1Disulfides 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Carcinoma × Gynecologic × Clear all
NCT02948426 2026-01-08

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
18 enrolled 19 charts
Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00565851 2025-12-30

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
1,052 enrolled 27 charts
Gynecologic

Brenner Tumor, Carcinoma, Adenocarcinoma, Mucinous, Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

NCT00001569 2008-03-04

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
74 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡